However , the proportion of atovaquone-proguanil-treated patients with positive smears on day 3 was much higher ( 36.0 % ; P < .05 ) than that of the artesunate-amodiaquine ( 2.9 % ) and artesunate-atovaquone-proguanil ( 1.0 % ) groups .